HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Steuerwald Selected Research

Viremia

2/2002Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Steuerwald Research Topics

Disease

2Liver Diseases (Liver Disease)
12/2006 - 08/2006
1COVID-19
07/2022
1Respiratory Insufficiency (Respiratory Failure)
07/2022
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
07/2022
1Acrodermatitis (Gianotti Crosti Syndrome)
02/2009
1Sacroiliitis
02/2009
1Fibrosis (Cirrhosis)
12/2006
1Non-alcoholic Fatty Liver Disease
12/2006
1Loiasis
08/2006
1Hepatitis
08/2006
1Pancreatitis
08/2005
1Chronic Hepatitis C
02/2002
1Viremia
02/2002

Drug/Important Bio-Agent (IBA)

1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2022
1Infliximab (Remicade)FDA Link
02/2009
1Vitamin EFDA LinkGeneric
12/2006
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
12/2006
1Ivermectin (Mectizan)FDA Link
08/2006
1Amantadine (Aman)FDA LinkGeneric
02/2002
1Interferon alpha-2 (Roferon-A)FDA Link
02/2002
1InterferonsIBA
02/2002

Therapy/Procedure

2Therapeutics
12/2006 - 02/2002
1Critical Care (Surgical Intensive Care)
07/2022
1Liver Transplantation
08/2005